- Report
- September 2024
- 87 Pages
Global
From €3500EUR$4,013USD£3,065GBP
- Report
- October 2022
- 171 Pages
Global
From €3335EUR$3,570USD£2,821GBP
The Hepatitis E Test market is a segment of the Infectious Diseases Drugs market. It is used to detect the presence of the hepatitis E virus (HEV) in a patient's blood. The test is used to diagnose acute and chronic hepatitis E infections, as well as to monitor the effectiveness of treatment. It is also used to screen blood donors for the virus. The test is typically performed using a combination of enzyme-linked immunosorbent assay (ELISA) and polymerase chain reaction (PCR) techniques.
The Hepatitis E Test market is expected to grow due to increasing prevalence of the virus, rising awareness of the disease, and the availability of improved diagnostic techniques. Additionally, the development of new treatments and vaccines for the virus is expected to drive the market.
Some companies in the Hepatitis E Test market include Abbott Laboratories, Bio-Rad Laboratories, DiaSorin, F. Hoffmann-La Roche, and Siemens Healthineers. Show Less Read more